Comparison of long-term clinical outcomes in the propensity-score matched population
| Propensity-score matched . | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group B . | Group P . | Adjusted HR (95% CI) . | P-value . | |||||
| Variables . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | ||
| All-cause mortality | 283/814 (34.8) | 6.7 (SD: 4.2) | 5.2 (4.6–5.8) | 311/814 (38.2) | 6.7 (SD: 3.9) | 5.7 (5.1–6.3) | 1.10 (0.94–1.30) | 0.24 |
| Stroke | 138/688 (20.1) | 6.1 (SD: 4.2) | 3.3 (2.8–3.9) | 123/688 (17.9) | 6.1 (SD: 4.2) | 2.9 (2.5–3.5) | 0.83 (0.65–1.07) | 0.15 |
| Ischaemic stroke | 126/688 (18.3) | 6.1 (SD: 4.2) | 2.9 (2.5–3.6) | 110/688 (16.0) | 6.2 (SD: 4.0) | 2.6 (2.2–3.1) | 0.82 (0.63–1.06) | 0.13 |
| Haemorrhagic stroke | 23/688 (3.3) | 6.7 (SD: 4.2) | 0.50 (0.33–0.75) | 20/688 (2.9) | 6.7 (SD: 3.8) | 0.43 (0.28–0.67) | 0.83 (0.45–1.53) | 0.55 |
| Reoperation | 22/814 (2.7) | 6.6 (SD: 4.1) | 0.41 (0.27–0.62) | 29/814 (3.6) | 6.6 (SD: 3.8) | 0.54 (0.38–0.78) | 1.37 (0.76–2.46) | 0.29 |
| Infective endocarditis | 51/814 (6.3) | 6.5 (SD: 4.2) | 0.97 (0.74–1.3) | 56/814 (6.9) | 6.4 (SD: 3.9) | 1.1 (0.83–1.4) | 1.10 (0.75–1.61) | 0.63 |
| Progression to CRF | 22/454 (4.9) | 6.7 (SD: 4.2) | 0.72 (0.47–1.1) | 26/454 (5.7) | 6.6 (SD: 3.9) | 0.87 (0.59–1.3) | 1.31 (0.71–2.43) | 0.38 |
| Propensity-score matched . | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group B . | Group P . | Adjusted HR (95% CI) . | P-value . | |||||
| Variables . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | ||
| All-cause mortality | 283/814 (34.8) | 6.7 (SD: 4.2) | 5.2 (4.6–5.8) | 311/814 (38.2) | 6.7 (SD: 3.9) | 5.7 (5.1–6.3) | 1.10 (0.94–1.30) | 0.24 |
| Stroke | 138/688 (20.1) | 6.1 (SD: 4.2) | 3.3 (2.8–3.9) | 123/688 (17.9) | 6.1 (SD: 4.2) | 2.9 (2.5–3.5) | 0.83 (0.65–1.07) | 0.15 |
| Ischaemic stroke | 126/688 (18.3) | 6.1 (SD: 4.2) | 2.9 (2.5–3.6) | 110/688 (16.0) | 6.2 (SD: 4.0) | 2.6 (2.2–3.1) | 0.82 (0.63–1.06) | 0.13 |
| Haemorrhagic stroke | 23/688 (3.3) | 6.7 (SD: 4.2) | 0.50 (0.33–0.75) | 20/688 (2.9) | 6.7 (SD: 3.8) | 0.43 (0.28–0.67) | 0.83 (0.45–1.53) | 0.55 |
| Reoperation | 22/814 (2.7) | 6.6 (SD: 4.1) | 0.41 (0.27–0.62) | 29/814 (3.6) | 6.6 (SD: 3.8) | 0.54 (0.38–0.78) | 1.37 (0.76–2.46) | 0.29 |
| Infective endocarditis | 51/814 (6.3) | 6.5 (SD: 4.2) | 0.97 (0.74–1.3) | 56/814 (6.9) | 6.4 (SD: 3.9) | 1.1 (0.83–1.4) | 1.10 (0.75–1.61) | 0.63 |
| Progression to CRF | 22/454 (4.9) | 6.7 (SD: 4.2) | 0.72 (0.47–1.1) | 26/454 (5.7) | 6.6 (SD: 3.9) | 0.87 (0.59–1.3) | 1.31 (0.71–2.43) | 0.38 |
CI: confidence interval; CRF: chronic renal failure; HR: hazard ratio; SD: standard deviation.
Comparison of long-term clinical outcomes in the propensity-score matched population
| Propensity-score matched . | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group B . | Group P . | Adjusted HR (95% CI) . | P-value . | |||||
| Variables . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | ||
| All-cause mortality | 283/814 (34.8) | 6.7 (SD: 4.2) | 5.2 (4.6–5.8) | 311/814 (38.2) | 6.7 (SD: 3.9) | 5.7 (5.1–6.3) | 1.10 (0.94–1.30) | 0.24 |
| Stroke | 138/688 (20.1) | 6.1 (SD: 4.2) | 3.3 (2.8–3.9) | 123/688 (17.9) | 6.1 (SD: 4.2) | 2.9 (2.5–3.5) | 0.83 (0.65–1.07) | 0.15 |
| Ischaemic stroke | 126/688 (18.3) | 6.1 (SD: 4.2) | 2.9 (2.5–3.6) | 110/688 (16.0) | 6.2 (SD: 4.0) | 2.6 (2.2–3.1) | 0.82 (0.63–1.06) | 0.13 |
| Haemorrhagic stroke | 23/688 (3.3) | 6.7 (SD: 4.2) | 0.50 (0.33–0.75) | 20/688 (2.9) | 6.7 (SD: 3.8) | 0.43 (0.28–0.67) | 0.83 (0.45–1.53) | 0.55 |
| Reoperation | 22/814 (2.7) | 6.6 (SD: 4.1) | 0.41 (0.27–0.62) | 29/814 (3.6) | 6.6 (SD: 3.8) | 0.54 (0.38–0.78) | 1.37 (0.76–2.46) | 0.29 |
| Infective endocarditis | 51/814 (6.3) | 6.5 (SD: 4.2) | 0.97 (0.74–1.3) | 56/814 (6.9) | 6.4 (SD: 3.9) | 1.1 (0.83–1.4) | 1.10 (0.75–1.61) | 0.63 |
| Progression to CRF | 22/454 (4.9) | 6.7 (SD: 4.2) | 0.72 (0.47–1.1) | 26/454 (5.7) | 6.6 (SD: 3.9) | 0.87 (0.59–1.3) | 1.31 (0.71–2.43) | 0.38 |
| Propensity-score matched . | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group B . | Group P . | Adjusted HR (95% CI) . | P-value . | |||||
| Variables . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | No. of events, (%) . | Follow-up duration (years) . | Incidence (%/patient-years) . | ||
| All-cause mortality | 283/814 (34.8) | 6.7 (SD: 4.2) | 5.2 (4.6–5.8) | 311/814 (38.2) | 6.7 (SD: 3.9) | 5.7 (5.1–6.3) | 1.10 (0.94–1.30) | 0.24 |
| Stroke | 138/688 (20.1) | 6.1 (SD: 4.2) | 3.3 (2.8–3.9) | 123/688 (17.9) | 6.1 (SD: 4.2) | 2.9 (2.5–3.5) | 0.83 (0.65–1.07) | 0.15 |
| Ischaemic stroke | 126/688 (18.3) | 6.1 (SD: 4.2) | 2.9 (2.5–3.6) | 110/688 (16.0) | 6.2 (SD: 4.0) | 2.6 (2.2–3.1) | 0.82 (0.63–1.06) | 0.13 |
| Haemorrhagic stroke | 23/688 (3.3) | 6.7 (SD: 4.2) | 0.50 (0.33–0.75) | 20/688 (2.9) | 6.7 (SD: 3.8) | 0.43 (0.28–0.67) | 0.83 (0.45–1.53) | 0.55 |
| Reoperation | 22/814 (2.7) | 6.6 (SD: 4.1) | 0.41 (0.27–0.62) | 29/814 (3.6) | 6.6 (SD: 3.8) | 0.54 (0.38–0.78) | 1.37 (0.76–2.46) | 0.29 |
| Infective endocarditis | 51/814 (6.3) | 6.5 (SD: 4.2) | 0.97 (0.74–1.3) | 56/814 (6.9) | 6.4 (SD: 3.9) | 1.1 (0.83–1.4) | 1.10 (0.75–1.61) | 0.63 |
| Progression to CRF | 22/454 (4.9) | 6.7 (SD: 4.2) | 0.72 (0.47–1.1) | 26/454 (5.7) | 6.6 (SD: 3.9) | 0.87 (0.59–1.3) | 1.31 (0.71–2.43) | 0.38 |
CI: confidence interval; CRF: chronic renal failure; HR: hazard ratio; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
